1. Home
  2. |Insights
  3. |Whistleblower Protections for Prime and Sub Employees Expanded

Whistleblower Protections for Prime and Sub Employees Expanded

Client Alert | 1 min read | 09.30.13

On September 30, 2013, the government amended the FAR and DFARS to enhance whistleblower protections for employees of government contractors and extend such protections to subcontractor employees. As discussed in a prior Crowell & Moring webinar, these enhanced protections, which also apply to non-defense contracts through a four-year "pilot program," broaden the scope of protected disclosures to include reporting an "abuse of authority," add new protections for internal disclosures to certain managerial employees, lower the burden of proof for demonstrating a "reprisal" against the whistleblower, and afford greater remedies such as compensatory damages and legal fees.


Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights